Hims & Hers (NYSE: HIMS) is disrupting the healthcare market with its innovative patient treatment approach. Read More: Earn ...

Hims & Hers offers personalized telehealth services, with a stock price that reflects high-growth potential. See why we ...

Shares of Hims & Hers Health jumped after the company added former Food and Drug Administration official Deb Autor to its board. The stock was up 8.8% at $21.02 in Monday trading. Shares have doubled ...

Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon One ...

Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower in possible response to Amazon.com Inc's (NASDAQ:AMZN) new ...

Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.’s latest push into healthcare will ...

Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hims & Hers Health (HIMS – Research Report) and Celcuity (CELC – Research Report). Don't Miss our Black ...

Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and ...

旧金山——根据最近的SEC文件，Hims & Hers Health Inc. (NYSE:HIMS)的首席会计官Becklund Irene于2024年11月18日执行了一系列股票交易。 Irene行权获得472股A类普通股，每股价格为9.41美元。随后，她以每股19.42美元的价格出售了相同数量的股票，总销售价值为9,166美元。这些交易是根据2023年9月11日采用的预先安排的交易计划进行的 ...

根据最近的SEC文件显示，Hims & Hers Health, Inc. (NYSE:HIMS)的首席运营官Melissa Baird近期出售了她持有的公司股票的一大部分。Baird于2023年11月18日总共出售了58,750股，获得约124万美元。这些股票的售价在每股20.4821美元至21.3026美元之间。 除了出售股票外，Baird还行权获得了58,750股，行权价为每股0.40美元， ...

Hims & Hers Health launched a GLP-1 Supply Tracker to spotlight challenges in accessing obesity medications, addressing ...